Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM score

BACKGROUND: We aimed to investigate the potential of standard hematologic and serum biochemical parameters to provide an independent and substantial contribution to the prediction of survival in patients with newly diagnosed brain metastases (BM). METHODS: Hemoglobin, white blood cell count, platele...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Berghoff, Anna S, Wolpert, Fabian, Holland-Letz, Tim, Koller, Romina, Widhalm, Georg, Gatterbauer, Brigitte, Dieckmann, Karin, Birner, Peter, Bartsch, Rupert, Zielinski, Christoph C, Weller, Michael, Preusser, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570252/
https://ncbi.nlm.nih.gov/pubmed/28096493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados